Straightforward Determination of Sodium Hyaluronate in Active Pharmaceutical Ingredient and Ophthalmic Formulations: Validation and Stability Study
Last updated: 03 Jan 2025
10.21608/aprh.2020.31754.1110
HPLC, sodium hyaluronate, SCHARLAU, ICH guidelines, Hycarenol® eye drops
Mohammed
El-Behairy
Department of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt.
mohabeha@gmail.com
Mostafa
Taher
Department of Research and Development (Methodology section), Egyptian Group for Pharmaceutical Industries Egypt. , Sanocare for Pharmaceutical Industries, Badr City, Egypt.
dr_mostafa_taher@yahoo.com
Inas
Abdallah
Department of Analytical Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt.
inas.abdallah@fop.usc.edu.eg
0000-0002-4207-0985
4
4
18058
2020-10-01
2020-06-03
2020-10-01
147
152
2357-0547
2357-0539
https://aprh.journals.ekb.eg/article_119889.html
https://aprh.journals.ekb.eg/service?article_code=119889
3
Research Article
318
Journal
Journal of Advanced Pharmacy Research
https://aprh.journals.ekb.eg/
Straightforward Determination of Sodium Hyaluronate in Active Pharmaceutical Ingredient and Ophthalmic Formulations: Validation and Stability Study
Details
Type
Article
Created At
22 Jan 2023